Isecophar SRL
Isecophar reported total assets of 292,254 € at the end of the 2025 financial year (annual accounts filed with the NBB on 17 Jun 2026).
The score of Isecophar shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +142 % Total assets +124 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Isecophar's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 50,170 € | ||||
| Equity | 273,568 € | ||||
| Cash | 278,549 € | ||||
| EBITDA | 78,771 € | ||||
| Total assets | 292,254 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 17 Jun 2026
- Year ended 31 Dec 2024filed on 20 Jun 2025
- Year ended 31 Dec 2023filed on 30 May 2024
- Year ended 31 Dec 2022filed on 31 Aug 2023
- Year ended 31 Dec 2021filed on 18 May 2022
Isecophar's financial analysis
- Solvency93.6%sector median: 58.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Isecophar
Isecophar's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0463.471.641
- VAT number
- BE0463471641
- Peppol
- Registered · 0208:0463471641 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 02 Jun 1998
- Registered office
- 1470 Genappe
- Latest accounts
- 2025 · filed on 17 Jun 2026
- Activity
- Activities in the field of nutrition (NACE 86995)
Isecophar (SRL) has been based in Genappe since 1998, active in: activities in the field of nutrition. For 2025, it reports a net profit of 50,170 € and equity of 273,568 €; its revenue is not published. Its solvency stands at 93.6%, above the median of its sector (58.4%).
Companies similar to Isecophar
Companies in the same business, of comparable size and area, outside its group.
- Hubert Services Management Retail sale of pharmaceutical products Estinnes · balance sheet 65,144 €
- Corbiopharm Retail sale of pharmaceutical products Bouillon · balance sheet 322,101 €
- Osteoserv Retail sale of pharmaceutical products Kinrooi · balance sheet 442,674 €
- JONCKHEERE Consultance Retail sale of pharmaceutical products Stavelot · balance sheet 460,876 €
- Apotheek Donk Retail sale of pharmaceutical products Herk-de-Stad · balance sheet 468,888 €
- Régine Pire Other human health activities n.e.c. Herve · balance sheet 54,245 €
- Revapunt Other human health activities n.e.c. Sint-Niklaas · balance sheet 243,964 €
- Groep SAM Other human health activities n.e.c. Bree · balance sheet 383,699 €
Frequently asked questions about Isecophar
What is the revenue of Isecophar?
Isecophar files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Isecophar?
In Belgium, the VAT number is the company number prefixed with BE: BE0463471641 for Isecophar, if the company is VAT-registered. Its company number (CBE) is 0463.471.641.
Where is the registered office of Isecophar?
According to the CBE register, the registered office of Isecophar is in 1470 Genappe.
What is the equity of Isecophar?
At the close of the 2025 financial year, the equity of Isecophar amounts to 273,568 €, a solvency of 93.6% of total assets.
Who manages Isecophar?
The register lists 1 active mandates at Isecophar. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Isecophar
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →